AUPO193196A0 - Substituted amine derivatives - Google Patents

Substituted amine derivatives

Info

Publication number
AUPO193196A0
AUPO193196A0 AUPO1931A AUPO193196A AUPO193196A0 AU PO193196 A0 AUPO193196 A0 AU PO193196A0 AU PO1931 A AUPO1931 A AU PO1931A AU PO193196 A AUPO193196 A AU PO193196A AU PO193196 A0 AUPO193196 A0 AU PO193196A0
Authority
AU
Australia
Prior art keywords
substituted amine
amine derivatives
derivatives
substituted
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO1931A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to AUPO1931A priority Critical patent/AUPO193196A0/en
Publication of AUPO193196A0 publication Critical patent/AUPO193196A0/en
Priority to PCT/JP1997/002876 priority patent/WO1998008838A1/en
Priority to JP10511454A priority patent/JP2000517314A/en
Priority to AU38666/97A priority patent/AU3866697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AUPO1931A 1996-08-27 1996-08-27 Substituted amine derivatives Abandoned AUPO193196A0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AUPO1931A AUPO193196A0 (en) 1996-08-27 1996-08-27 Substituted amine derivatives
PCT/JP1997/002876 WO1998008838A1 (en) 1996-08-27 1997-08-20 Substituted amine derivatives
JP10511454A JP2000517314A (en) 1996-08-27 1997-08-20 Substituted amine derivatives
AU38666/97A AU3866697A (en) 1996-08-27 1997-08-20 Substituted amine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO1931A AUPO193196A0 (en) 1996-08-27 1996-08-27 Substituted amine derivatives

Publications (1)

Publication Number Publication Date
AUPO193196A0 true AUPO193196A0 (en) 1996-09-19

Family

ID=3796244

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO1931A Abandoned AUPO193196A0 (en) 1996-08-27 1996-08-27 Substituted amine derivatives

Country Status (3)

Country Link
JP (1) JP2000517314A (en)
AU (1) AUPO193196A0 (en)
WO (1) WO1998008838A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3824735B2 (en) * 1997-05-13 2006-09-20 ポーラ化成工業株式会社 Amine derivatives
CA2460789C (en) * 2001-09-18 2011-06-21 Ishihara Sangyo Kaisha, Ltd. Acid amide derivatives, process for their production and pesticides containing them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03141275A (en) * 1989-10-25 1991-06-17 Banyu Pharmaceut Co Ltd Substituted allylamine derivative and its use
CA2038633A1 (en) * 1990-03-20 1991-09-21 Yoshimi Tsuchiya Substituted amine derivatives having anti-hyperlipemia activity
WO1993012069A1 (en) * 1991-12-16 1993-06-24 Yamanouchi Pharmaceutical Co., Ltd. Novel amino alcohol derivative or salt thereof
JPH05213923A (en) * 1992-02-06 1993-08-24 Yamanouchi Pharmaceut Co Ltd New thioamide derivative or its salt
AU5979594A (en) * 1993-02-05 1994-08-29 Yamanouchi Pharmaceutical Co., Ltd. Novel amine derivative

Also Published As

Publication number Publication date
JP2000517314A (en) 2000-12-26
WO1998008838A1 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
AUPO395396A0 (en) Benzamide derivatives
AU1151099A (en) Azaoxindole derivatives
AU3698295A (en) Amino purine-beta -d-ribofuranuronamide derivatives
AU1825899A (en) Dota-biotin derivatives
AU7935398A (en) Diaminorhodamine derivatives
AU6117998A (en) 3-oxadiazolylquinoxaline derivatives
AU1735497A (en) Sulfonylureidopyrazole derivatives
AU1594697A (en) New substituted 19-nor-pregnane derivatives
AU7738098A (en) Novel tetrahydrobenzindolone derivatives
AU3867997A (en) Chromene-3-carboxylate derivatives
AU2956097A (en) Alkylaminobenzothiazole and -benzoxazole derivatives
EP1008579A3 (en) Cyclopentenebutanol derivatives
AU2961097A (en) Substituted pyrazolylpyrazole derivatives
AU7813598A (en) Betulinol derivatives
AU4962097A (en) 2-methoxyphenylpiperazine derivatives
AU4616897A (en) Amine salts
AU1793197A (en) Pyrazole-4-yl-hetaroyl derivatives
AUPO863197A0 (en) Novel derivatives
AU6729498A (en) Thiazolimine derivatives
AU1174199A (en) Biphenylamidine derivatives
AU3685097A (en) N-benzylazolium derivatives
AU6115798A (en) Saponarin derivatives
AU1562199A (en) Amino-benzothiazole derivatives
AU4300696A (en) Substituted m-biphenyloxazoline derivatives
AU4260296A (en) Novel pyrimidinyloxy- and pyrimidinylamino-ethylphenyl-dioxolane derivatives